These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8325621)

  • 1. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.
    Wood AJ; Villeneuve JP; Branch RA; Rogers LW; Shand DG
    Gastroenterology; 1979 Jun; 76(6):1358-62. PubMed ID: 437433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; Gariépy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the hepatic elimination of oxidized and of glucoronidated high clearance drugs following acute administration of carbon tetrachloride.
    Callaghan R; Paull P; Desmond PV; Mashford ML
    J Hepatol; 1994 Jun; 20(6):742-9. PubMed ID: 7930474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal metabolism of morphine in cirrhosis.
    Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in hepatic endothelin-1 clearance in cirrhosis.
    Tran Duc AT; Schwab AJ; Simard A; Villeneuve L; Dupuis J
    Clin Sci (Lond); 2003 Aug; 105(2):227-34. PubMed ID: 12708965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right heart failure impairs hepatic elimination of p-nitrophenol without inducing changes in content or latency of hepatic UDP-glucuronosyltransferases.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    J Pharmacol Exp Ther; 2000 Nov; 295(2):830-5. PubMed ID: 11046125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic extraction of long- and short-acting narcotics in the isolated perfused rabbit liver.
    Kreek MJ; Oratz M; Rothschild MA
    Gastroenterology; 1978 Jul; 75(1):88-94. PubMed ID: 401102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.
    Reichen J; Egger B; Ohara N; Zeltner TB; Zysset T; Zimmermann A
    J Clin Invest; 1988 Dec; 82(6):2069-76. PubMed ID: 3198765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased activity of hepatic alkaline protease in rats with carbon tetrachloride-induced liver cirrhosis.
    Abraham P; Wilfred G; Ramakrishna B
    Indian J Exp Biol; 1999 Dec; 37(12):1243-4. PubMed ID: 10865892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
    Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in pentobarbital and meperidine pharmacokinetics induced by bile duct ligation in the rat.
    Knodell RG; Brooks DA; Allen RC; Kyner WT
    J Pharmacol Exp Ther; 1980 Dec; 215(3):619-25. PubMed ID: 7441521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
    Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
    J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.